Latest Business Development News

ClearVue Technologies initiates a thorough expenditure review and announces a key board resignation as it aims to sharpen its focus on product innovation and global expansion.

Vitasora Health has completed the first tranche of its $11 million capital raise, positioning the company to fund growth initiatives and reach cash flow breakeven in the second half of fiscal 2026.

Locate Technologies has successfully raised nearly $400,000 through its ATM facility, bolstering its cash reserves to support growth in its delivery optimisation platforms.

SciDev Limited has secured $21.5 million in new contracts and renewals across oil & gas, mining, and PFAS remediation sectors, boosting its FY26 revenue guidance to $120-$140 million.

Memphasys Limited has submitted its CE Mark application for the Felix™ sperm separation device, targeting regulatory clearance within 6-12 months to unlock the lucrative European IVF market and accelerate approvals in other key regions.

Ronin Resources Limited updates ASX on delayed exploration activities and relinquished projects, citing socio-political challenges and market conditions. The company anticipates key licence grants by August 2025 and confirms compliance with listing rules while seeking new opportunities.

Alligator Energy has raised A$17.25 million through a strongly supported placement to institutional investors, positioning the company to advance key development stages at its Samphire Uranium Project. The funds will underpin exploration, feasibility studies, and the upcoming Field Recovery Trial.

South Harz Potash Limited has launched a two-tranche equity raising to secure up to A$3.11 million, aiming to advance its dual-asset strategy and strengthen its position in the European potash market.

AdAlta Limited has successfully placed the remaining shortfall in its renounceable rights issue, raising a total of $1.3 million to advance its cellular immunotherapy pipeline. The company also addressed an administrative breach involving director share allocations, ensuring compliance with ASX rules.

PainChek has advanced its US regulatory approval process with a positive FDA meeting, setting the stage for a potential market debut of its pain assessment app in late 2025.

Locate Technologies has made a strategic move by investing A$1 million in Bitcoin, aiming to leverage cryptocurrency as a growth catalyst while continuing to advance its core delivery platforms.

Codeifai Limited has locked in $570,000 through a discounted share placement, aiming to fuel its digital platform growth and strategic initiatives.